ARTICLE
|
doi:10.20944/preprints202207.0371.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biosymilars; metastatic breast cancer; trastuzumab; cost; her2; PTH
Online: 25 July 2022 (10:05:29 CEST)